Stock NRXS NEURAXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights NeurAxis, Inc.

Equities

NRXS

US64134X2018

Market Closed - Nyse
Other stock markets
 21:10:00 14/06/2024 BST 		5-day change 1st Jan Change
2.97 USD -1.00% Intraday chart for NeurAxis, Inc. -0.67% +11.24%
06-07 NeurAxis Submits Application to FDA to Expand IB-Stim Label MT
05-22 Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NeurAxis Submits Application to FDA to Expand IB-Stim Label
MT
Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635
MT
Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025
CI
NeurAxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NeurAxis, Inc. Provides Revenue Guidance in Late 2024 and into 2025
CI
NeurAxis, Inc. Announces IB-Stim Results from A Large, Pediatric, Multi-Center Registry
CI
NeurAxis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
NeurAxis, Inc. Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
CI
NeurAxis, Inc. Announces Results of Comparative Study of IB-Stim and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
CI
Earnings Flash (NRXS) NEURAXIS Posts Q2 Revenue $646,000
MT
NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
NeurAxis, Inc. Announces Publication of Prospective Study Showing IB-Stim Improves Quality of Life of Adolescents with IBS
CI
Neuraxis, Inc. Highlights Pediatric Post-Concussion Clinical Study
CI
NeurAxis, Inc. has completed an IPO in the amount of $6.592002 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRXS Stock
  4. News NeurAxis, Inc.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW